117 data "https:" "https:" "https:" "https:" "Uppsala universitet" Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
About the role We seek a motivated Postdoctoral Researcher to make use of spatial proteome and transcriptional cell atlas data to explore how two microbial cells can manifest stable endosymbiotic
-
role focuses on the computational analysis and methodological development of third-generation and single-cell sequencing data to understand the role of transposable elements (TEs) in early mammalian
-
-learning models based on first-principles data and apply these methods across increasingly complex structures and chemical systems. The role will involve both methodological development (datasets, models
-
it is imperative that samples are promptly received and processed in a timely and rigorous manner, and all data and methodology is recorded in an organised and precise manner electronically
-
computational biologists, immunologists, clinicians, and experimental scientists, you will support study design, data interpretation, and reporting, and contribute to the development of robust, reproducible
-
ability to write clean, well-documented analysis code. Ability to work with EEG data and apply multivariate methods to extract meaningful measures relevant to memory and consolidation. Skilled in developing
-
demonstrable molecular biology skills. You will be able to design the experiments, execute the experiment using various molecular biology techniques, and help analyse the data. You will have highly effective
-
on patient perspectives and aims to understand the information older people need about the harms and benefits of prostate specific antigen (PSA) testing (ProsDetect II). The second project addresses challenges
-
communication skills, including the ability to write text that can be published, present data at conferences, and represent the research group at meetings. This full-time post is available immediately and is
-
of human samples collected as part of this clinical trial must comply with the Medicines for Human Use (Clinical Trials) Regulations 2004 and will provide the primary endpoint data that will dictate